Shkreli is accused of defrauding his former drug company out of millions to pay back hedge-fund investors he allegedly ripped off. » Read More
Novozymes CEO Peder Holk speaks about earnings, adding that he believes that the company will return to its historical growth rates of 6-7 percent. » Read More
Waters CEO Chris O'Connell discusses the quarterly earnings for the scientific instrument and services company, its growth trajectory and tax position. » Read More
Eli Lilly reported a bigger-than-expected profit as the drugmaker benefited from higher demand for its newer products including diabetes treatment Trulicity. » Read More
Get the best of CNBC in your inbox
Dan Mangan is a reporter covering health care for CNBC.com.
Meg Tirrell joined CNBC in April 2014 as a general assignment reporter focusing on biotechnology and pharmaceuticals.
Bertha Coombs is a general assignment reporter for CNBC, covering financial markets and business news stories.